Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Wiener Klinische Wochenschrift|August 30, 2008
[Pathophysiology and therapy of benign prostatic hyperplasia]Natalie Sampson, Stephan Madersbacher, Peter Berger
Biomed Research International|April 5, 2014
Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic diseaseNatalie Sampson, Peter Berger, Christoph Zenzmaier
Gerontology|April 4, 2019
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-ReviewStephan Madersbacher, Natalie Sampson, Zoran Culig
Oxidative Medicine and Cellular Longevity|November 15, 2012
Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic diseaseNatalie Sampson, Peter Berger, Christoph Zenzmaier
Cancer Letters|August 2, 2015
The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancerIsabel Heidegger, Petra Massoner, Natalie Sampson, et al.
The Prostate|June 15, 2013
Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancerChristoph Zenzmaier, Natalie Sampson, Eugen Plas, et al.
The American Journal of Pathology|August 14, 2012
PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancerNatalie Sampson, Christian Ruiz, Christoph Zenzmaier, et al.
Endocrine-Related Cancer|March 1, 2013
In vitro model systems to study androgen receptor signaling in prostate cancerNatalie Sampson, Hannes Neuwirt, Martin Puhr, et al.
American Journal of Public Health|January 26, 2022
West Oakland's Experience in Building Community Power to Confront Environmental Injustice Through California's Assembly Bill 617Lily MacIver, Jonathan London, Natalie Sampson, et al.
Pageof 4